SYNGENE INTERNATIONAL
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Syngene International along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.32₹ 2.05
As on Oct 31, 2025, 4:01 PM IST
Syngene International Price Performance
Today's LowToday's High
₹648.40₹657.00
₹652.60
52 Weeks' Low52 Weeks' High
₹598.55₹960.00
₹652.60
Open Price
₹652.80
Prev. Close
₹650.55
Volume
4,122
Over the last 5 years, the share price of Syngene International has gained 4.29% CAGR. Over the past year, the corresponding return has been -24.10%.
Syngene International’s current P/E of 51.85x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Syngene International Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syngene International | -1.18 | 3.37 | -8.52 | 3.94 | -24.10 | 1.12 | 4.29 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Syngene International has declined 24.10% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Syngene International has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Syngene International Financials
Syngene International Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 656.38 | 654.6 |
| 10 | 645.91 | 651.39 |
| 20 | 639.25 | 647.28 |
| 50 | 647.26 | 648.26 |
| 100 | 653.02 | 657.29 |
| 200 | 679.22 | 683.24 |
Syngene International Share Holding Pattern
In the latest quarter, Syngene International remained same as its previous close in promoter holding, while DII stake increased to 24.62%, FII holding fell to 16.31%, and public shareholding moved down to 6.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Syngene International Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 40,79,850 | 0.38 | 254.11 | |
| 37,70,138 | 1.63 | 234.82 | |
| 37,37,983 | 1.39 | 232.82 | |
| 37,08,177 | 2.73 | 230.96 | |
| 33,69,970 | 1.32 | 209.9 | |
| 32,73,806 | 1.32 | 203.91 | |
| 31,86,400 | 0.49 | 198.46 | |
| 29,23,957 | 0.7 | 182.12 | |
| 28,00,121 | 0.26 | 174.41 | |
| 24,22,041 | 0.6 | 150.86 |
* Excluding Index & Arbitrage Funds
Syngene International Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Syngene International Options
Syngene International Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 3:06 AM IST | Syngene Internationa - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 28, 2025, 9:55 PM IST | Syngene Internationa - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 24, 2025, 3:33 AM IST | Syngene Internationa - Rumour verification - Regulation 30(11) |
| Oct 23, 2025, 7:42 PM IST | Syngene Internationa - Clarification sought from Syngene International Ltd |
| Oct 19, 2025, 2:46 AM IST | Syngene Internationa - Email Communication To Shareholders Under 100 Days Campaign - ''''Saksham Niveshak'''' |
About Syngene International
Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 3373.30 Cr. and Equity Capital is Rs. 402.50 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBiocon SEZ, Biocon Park, Bengaluru Karnataka 560099
- Contact
Management
- Ms. Kiran Mazumdar ShawNon Executive Chairman
- Mr. Peter BainsManaging Director & CEO
- Prof. Catherine RosenbergNon Executive Director
- Ms. Vinita BaliLead Independent Director
- Mr. Nilanjan RoyIndependent Director
- Dr. Kush ParmarIndependent Director
- Ms. Sharmila Abhay KarveIndependent Director
- Dr. Vijay KuchrooIndependent Director
- Mr. Manja BoermanIndependent Director
FAQs on Syngene International Share Price
What is the share price of Syngene International?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syngene International is ₹652.60 as on Oct 31, 2025.
What kind of stock is Syngene International?
The Syngene International is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Syngene International?
The market cap of Syngene International is ₹26,295.83 Cr as on Oct 31, 2025.
What are today's High and Low prices of Syngene International?
Today’s highest and lowest price of Syngene International are ₹657.00 and ₹648.40.
What are the 52 Week High and 52 Week Low of Syngene International?
The 52-week high/low is the highest and lowest price at which Syngene International stock has traded in the past 52-week or nearly a year. The 52-week high of Syngene International is ₹960.00 and 52-week low of Syngene International is ₹598.55 as on Oct 31, 2025.
How has the Syngene International performed historically in terms of returns?
The Syngene International has shown returns of 0.32% over the past day, 3.37% for the past month, -8.52% over 3 months, -24.1% over 1 year, 1.12% across 3 years, and 4.29% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Syngene International?
P/E ratio of and PB ratio of Syngene International are 51.85 and 5.98 on Oct 31, 2025. While the company gives a dividend yield of 0.19 per annum.
Syngene International News
✕
Market Pulse